Benjamin Brewer
Family Medicine · Forrest, ILNPI 1184618258
Payments from drug & device makers
Across 420 payments — averaging $31.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Novo Nordisk$688
- Radius Health, Inc.$389
- Merck$381
- GSK$305
- Pfizer$263
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$6,65450%
- Food & beverage$6,53350%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 148 | $8,822 |
| Novo Nordisk | 51 | $688 |
| Radius Health, Inc. | 20 | $389 |
| Merck | 28 | $381 |
| GSK | 26 | $305 |
| Pfizer | 16 | $263 |
| Aimmune Therapeutics, Inc. | 10 | $233 |
| Novartis | 9 | $217 |
| Amgen | 13 | $199 |
| Boehringer Ingelheim | 12 | $189 |
| Lilly USA, LLC | 12 | $168 |
| AstraZeneca | 7 | $147 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $108 |
| Nestle Healthcare Nutrition Inc. | 6 | $100 |
| Exact Sciences | 5 | $94 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $83 |
| Dexcom, Inc. | 4 | $77 |
| Johnson & Johnson | 4 | $74 |
| Mylan Specialty L.p. | 4 | $70 |
| Axsome Therapeutics, Inc. | 2 | $64 |
| Biohaven Pharmaceuticals, Inc. | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Organon | 4 | $55 |
| Sanofi Pasteur Inc. | 3 | $55 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Esperion Therapeutics, Inc. | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Biofire Diagnostics, LLC | 1 | $36 |
| Verona Pharma, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Echosens North America, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Alvogen Inc | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$243
How this compares
$13,196 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 274 | $138,910 |
| OzempicSemaglutide | 131 | $123,353 |
| JardianceEmpagliflozin | 108 | $94,297 |
| VraylarCariprazine Hcl | 39 | $53,342 |
| MounjaroTirzepatide | 31 | $47,739 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $33,858 |
| TrulicityDulaglutide | 22 | $29,762 |
| ZenpepLipase/Protease/Amylase | 13 | $25,174 |
| NuedextaDextromethorphan Hbr/Quinidine | 23 | $17,922 |
| Aripiprazole | 32 | $14,980 |
| EprontiaTopiramate | 16 | $13,327 |
| EntrestoSacubitril/Valsartan | 19 | $12,334 |
| JanuviaSitagliptin Phosphate | 27 | $11,910 |
| TradjentaLinagliptin | 21 | $11,302 |
| Risperidone ErRisperidone Microspheres | 19 | $10,268 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $263 | $138,910274 claims |
| Novo NordiskOzempic, Rybelsus | $688 | $133,427142 claims |
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi | $189 | $114,715141 claims |
| Lilly USA, LLCMounjaro, Trulicity | $168 | $77,50153 claims |
| AbbVieVraylar | $8,822 | $53,34239 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $305 | $49,24295 claims |
| Aimmune Therapeutics, Inc.Zenpep | $233 | $25,17413 claims |
| MerckJanuvia, Belsomra | $381 | $18,28961 claims |
| NovartisEntresto | $217 | $12,33419 claims |
| Johnson & JohnsonXarelto | $74 | $5,78020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Forrest
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.